Jens Wiehler

Dr. Jens Wiehler

Digital Health Lead, BioM Biotech Cluster Development | Managing Director DigiMed Bayern

Jens Wiehler is a Molecular Biologist with background in population genetics (Diploma, CAU Kiel) and protein engineering (PhD, Gene Center of the LMU Munich). In 2001 he joined the bioinformatics company Biomax Informatics AG as Key Account Manager. From 2006 to 2016 at the Eurofins Group, finally as Head of Business Development, he was building up diverse applied genomics service lines to European top 1-3 positions. From 2016 to 2018 as Business Unit Manager, Jens founded and managed a Eurofins-internal startup for consumer genomics.
In 2018, he joined BioM to help setting up the Bavarian flagship research program for P4 medicine, DigiMed Bayern, for which he is since then Managing Director. DigiMed Bayern aims to implement data and digitally driven medicine of the future, exemplified by the widespread disease atherosclerosis. DigiMed Bayern is being funded by the Bavarian Ministry of Health with a total of €24.5 million until the end of 2024. It includes clinical and epidemiological studies with deep multi-omics approaches, the development of the “HerzFit” prevention app with >130.000 downloads so far, and progressive fundamental development of health data IT infrastructure. Jens is also involved in the areas of innovation, biotech clusters, and policy advice. A current central field of activity is contributing to the development of a collaborative Bavarian-based “trusted research environment” in the context of the emerging European Health Data Space, EHDS.

speichern